# Roundup

Type: Product

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/roundup
Canonical HTML page: https://getbiobrief.com/entity/roundup

## Timeline

- **2047-02-18**: End of Certainty Period — The 21-year structured resolution period is slated to conclude.
- **2026-02-18**: $7.25B Settlement Announced — Bayer agrees to a new $7.25 billion deal with a 21-year certainty plan.
- **2020-06-24**: Initial $10B Settlement — Bayer announces a massive settlement to resolve current claims, but future liability remains.
- **2018-06-07**: Monsanto Acquisition — Bayer completes $63 billion acquisition of Monsanto, inheriting Roundup litigation.

## Recent coverage (2 stories)

### Roundup Ruling: 7-2 SCOTUS Verdict Reduces Bayer's Liability by Billions
2026-06-30 23:00:25 · Sentiment: Neutral · Impact: 7/10 · Sources: 2

The U.S. Supreme Court ruled that FIFRA preempts state failure-to-warn claims against Bayer's Roundup, eliminating a massive source of litigation uncertainty. The 7-2 decision validates EPA's safety assessment of glyphosate and sharply reduces Bayer's outstanding tort exposure, potentially freeing up billions in capital for the biotech giant.
Full story: https://getbiobrief.com/story/scotus-fifra-roundup-bayer-biotech

### Bayer Agrees to Landmark $7.25B Roundup Settlement to End Decades of Litigation
2026-02-18 22:25:49 · Sentiment: Negative · Impact: 8/10 · Sources: 2

Bayer has reached a $7.25 billion settlement agreement to resolve long-standing litigation surrounding its Roundup herbicide. The deal includes a 21-year framework designed to provide legal and financial certainty for the company following years of costly courtroom battles.
Full story: https://getbiobrief.com/story/bayer-7-25b-roundup-settlement-21-year-plan

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.